1
Spekhorst, LM, Oldenburg, B, van Bodegraven, AA, de Jong, DJ, Imhann, F, de Jong, AE, Pierik, MJ, van der Woude, C.J., Dijkstra, G, D'Haens, G, Lowenberg, M, Weersma, RK, Festen, EAM
Veröffentlicht in: Spekhorst , LM , Oldenburg , B , van Bodegraven , AA , de Jong , DJ , Imhann , F , de Jong , AE , Pierik , MJ , van der Woude , C J , Dijkstra , G , D'Haens , G , Lowenberg , M , Weersma , RK & Festen , EAM 2017 , ' Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease ' , World Journal of Gastroenterology , vol. 23 , no. 46 , pp. 8182-8192 . https://doi.org/10.3748/wjg.v23.i46.8182;
2017
Veröffentlicht in: Spekhorst , LM , Oldenburg , B , van Bodegraven , AA , de Jong , DJ , Imhann , F , de Jong , AE , Pierik , MJ , van der Woude , C J , Dijkstra , G , D'Haens , G , Lowenberg , M , Weersma , RK & Festen , EAM 2017 , ' Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease ' , World Journal of Gastroenterology , vol. 23 , no. 46 , pp. 8182-8192 . https://doi.org/10.3748/wjg.v23.i46.8182;
2017
2
Biemans, VBC, Sleutjes, Jasmijn, de Vries, Annemarie, Bodelier, AG, Dijkstra, A, Oldenburg, B, Löwenberg, M, van Bodegraven, AA, de Jong, AEE, de Boer, NK, Srivastava, N, West, RL, Römkens, TEH, Horjus Talabur Horje, CS, Jansen, J, van der Woude, C.J., Hoekstra, J, Weersma, RK, van Schaik, FDM, Hoentjen, F, Pierik, MJ
Veröffentlicht in: Biemans , VBC , Sleutjes , J , de Vries , A , Bodelier , AG , Dijkstra , A , Oldenburg , B , Löwenberg , M , van Bodegraven , AA , de Jong , AEE , de Boer , NK , Srivastava , N , West , RL , Römkens , TEH , Horjus Talabur Horje , CS , Jansen , J , van der Woude , C J , Hoekstra , J , Weersma , RK , van Schaik , FDM , Hoentjen , F & Pierik , MJ 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology and Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020
Veröffentlicht in: Biemans , VBC , Sleutjes , J , de Vries , A , Bodelier , AG , Dijkstra , A , Oldenburg , B , Löwenberg , M , van Bodegraven , AA , de Jong , AEE , de Boer , NK , Srivastava , N , West , RL , Römkens , TEH , Horjus Talabur Horje , CS , Jansen , J , van der Woude , C J , Hoekstra , J , Weersma , RK , van Schaik , FDM , Hoentjen , F & Pierik , MJ 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology and Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020